NTRK1 and lung carcinoma: Tyrosine kinase receptor ligands, such as platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), and fibroblast growth factor (FGF), are aberrantly expressed in lung cancer and IPF (114).